The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

S. Kusamura, Pilar Adriana Torres Mesa, A. Cabras, Dario Baratti, M. Deraco

Research output: Contribution to journalArticlepeer-review

Cite this